Skip to main content Skip to Footer


Technology Vision for Life Sciences - 2015

Digital is influencing the life sciences technology landscape and driving a new era—the life sciences “digital ecosystem.”


Succeeding in the “we economy”

Companies are connected to a digital fabric and a global network that has the potential to touch all aspects of their business. This grand network of businesses, individuals and things has the power to introduce a new era in the digital age—the age of “digital ecosystems”.

The Accenture Technology Vision 2015 surveyed the opinions of 1000+ C-suite and D-suite executives across industries from around the world about the technology trends. 100+ senior executives from life sciences firms participated in the survey across key developed and developing markets. Key digital trends and their likely impact were assessed in the survey.

Trend 1

The Internet of Me: Healthcare personalized

Welcome to the era of highly personalized care, monitoring and treatment, building trust through meaningful patient experiences.

“In the US branded pharmaceutical market, customer experience could drive


in incremental revenue, according to Accenture Analysis.”
How is the life sciences industry impacted?
Engage in the wellness revolution
Personalize the patient journey
Establish and maintain trusted, digital havens

Trend 2

Outcome Economy: Hardware producing health results

New intelligence in embedded hardware and sensors is giving patients and healthcare providers what they really want: meaningful outcomes.



How is the life sciences industry impacted?

Drive patient outcomes
Adapt to a risk-adjusted pricing world
Re-invent R&D
Own the platforms of the upcoming sharing economy

Trend 3

The Platform (R)evolution: Defining ecosystems, redefining life sciences

Healthcare IT platforms capture data from disparate sources (e.g., wearables, phones, glucometers), and connect it to bring a new era of personalized treatment through innovative patient services.


For each type 2 diabetes patient, at least $697 per year could be saved by using digitally accessed intermediaries and remote monitoring for diagnosis and treatment—resulting in total annual savings of $19.2 billion.”

How is the life sciences industry impacted?

Platform businesses are changing the world. According to Massachusetts Institute of Technology, “In 2013, 14 of the top 30 global brands by market capitalization were platform oriented companies—companies that created and now dominate arenas in which buyers, sellers, and a variety of third parties are connected in real time.” For life sciences we see potential for disruptors to emerge in four key ecosystems:

Regulatory and reimbursement

Trend 4

Intelligent Enterprise: Huge data, smarter systems, better healthcare solutions

A data explosion, accompanied by advances in processing power, health analytics and cognitive technology, is fueling software intelligence. Medical devices and wearables can now recognize, “think” and respond to make rapid better informed decisions.


“Over 40% of life sciences companies surveyed expect to see data volumes increase by at least 50% in the coming year.”

How is the life sciences industry impacted?
Establish the data supply chain
Invest in software intelligence to improve big-data analytical capabilities

Trend 5

Workforce Reimagined: Collaboration at the intersection of humans and healthcare

As the digital revolution gains momentum, scientists and life sciences professionals are now using machines to be more efficient, provide better decisions and take on increasingly more complex tasks.


“Of all life sciences respondents believe that companies will need to focus on training their machines as much as they do on training their people (e.g., using intelligent software, algorithms and machine learning).”

How is the life sciences industry impacted?

1. Augment workforce productivity

Augmented devices (e.g., smart glasses, wearables, immersive technologies, and NLP) providing more portability, insights, and unprecedented contextual information to scientists, clinicians, and doctors during the research, drug development and clinical trials process.

2. Expand training

Life sciences companies will need to identify how to train and certify both human and machine interfaces for R&D, manufacturing, and sales divisions.


To capture the bigger prize, life sciences companies must embrace digital holistically to improve patients' quality of life and capture the more than $100 billion of commercial value in the US over the next 5 years.

9 out of 10

9 out of 10

life sciences respondents believe that industry boundaries will dramatically blur as platforms reshape industries into interconnected ecosystems.


believe that the next generation of platforms will not be led by tech companies, but by industry players and leaders


plan to engage with new digital partners in the industry in the next 2 years


are already using industry platforms to integrate data with digital business partners, while 26% are experimenting with such platforms